Algernon Health
Delta
About Algernon Health
Breathtec Biomedicala medical diagnostics company focused on developing, in-licensing, and commercializing proprietary innovative. Breathtec Biomedical (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Their efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung and breast cancers, neurodegenerative diseases like Alzheimer's, Parkinson's, tuberculosis, diabetes, liver disease, and more.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: fra:AGW
- Website: algernonhealth.com
- Phone: +1 (604) 805-4602
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/algernon-health-158180 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.